Robert C. Brasch
#143,617
Most Influential Person Now
Robert C. Brasch's AcademicInfluence.com Rankings
Robert C. Braschchemistry Degrees
Chemistry
#3726
World Rank
#4766
Historical Rank
Inorganic Chemistry
#185
World Rank
#198
Historical Rank
Physical Chemistry
#529
World Rank
#580
Historical Rank
Download Badge
Chemistry
Robert C. Brasch's Degrees
- PhD Chemistry University of California, Berkeley
- Bachelors Chemistry University of California, Berkeley
Why Is Robert C. Brasch Influential?
(Suggest an Edit or Addition)Robert C. Brasch's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. (1984) (1233)
- Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. (2000) (437)
- Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex. (1984) (315)
- Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. (1998) (281)
- Work in progress: methods of contrast enhancement for NMR imaging and potential applications. A subject review. (1983) (246)
- Cystic fibrosis: CT assessment of lung involvement in children and adults. (1999) (227)
- Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor. (1998) (214)
- Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. (1996) (208)
- Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: biodistribution and imaging studies. (1987) (203)
- Effect of gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardium. (1984) (196)
- New directions in the development of MR imaging contrast media. (1992) (178)
- Normal deposition of brain iron in childhood and adolescence: MR imaging at 1.5 T. (1989) (169)
- Pediatric pulmonary disease: assessment with high-resolution ultrafast CT. (1990) (163)
- Rationale and applications for macromolecular Gd‐based contrast agents (1991) (162)
- MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report. (2000) (159)
- Dynamic contrast‐enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti‐angiogenic therapy in a xenograft model of glioblastoma multiforme (2002) (154)
- Work in progress: nuclear magnetic resonance study of a paramagnetic nitroxide contrast agent for enhancement of renal structures in experimental animals. (1983) (145)
- MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation. (2001) (143)
- Acute myocardial ischemia: magnetic resonance contrast enhancement with gadolinium-DTPA. (1984) (143)
- In vivo monitoring of tumor angiogenesis with MR imaging. (2000) (139)
- Magnetic resonance imaging of transfusional hemosiderosis complicating thalassemia major. (1984) (135)
- AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging. (2007) (134)
- Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues. (1990) (131)
- Tumor microvascular changes in antiangiogenic treatment: Assessment by magnetic resonance contrast media of different molecular weights (2004) (128)
- Factors affecting nitroxide reduction in ascorbate solution and tissue homogenates. (1985) (116)
- Gd-DTPA in clinical MR of the brain: 1. Intraaxial lesions. (1986) (115)
- Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors. (2001) (113)
- Contrast-enhanced MR imaging of the lung: assessments of ventilation and perfusion. (1992) (110)
- Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats. (1992) (110)
- Assessment of myocardial salvage after ischemia and reperfusion using magnetic resonance imaging and spectroscopy. (1989) (109)
- Contrast-enhanced MR imaging assessment of tumor capillary permeability: effect of irradiation on delivery of chemotherapy. (1996) (100)
- Influence of severity of myocardial injury on distribution of macromolecules: extravascular versus intravascular gadolinium-based magnetic resonance contrast agents. (1997) (97)
- Bone marrow in children with acute lymphocytic leukemia: MR relaxation times. (1986) (96)
- Effect of varying the molecular weight of the MR contrast agent Gd‐DTPA‐polylysine on blood pharmacokinetics and enhancement patterns (1994) (96)
- Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media (1998) (95)
- Comparison of the contrast-enhancing properties of albumin-(Gd-DTPA) and Gd-DTPA at 2.0 T: and experimental study in rats. (1986) (95)
- Quantification of the extraction fraction for gadopentetate across breast cancer capillaries (1998) (93)
- Neuroblastoma: diagnostic imaging and staging. (1983) (93)
- Dendritic iodinated contrast agents with PEG-cores for CT imaging: synthesis and preliminary characterization. (2006) (90)
- A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution (1997) (88)
- Reconstructive surgery for obstructing lesions of the intrathoracic trachea in infants and small children. (1982) (87)
- Prostate cancer tumor grade differentiation with dynamic contrast-enhanced MR imaging in the rat: comparison of macromolecular and small-molecular contrast media--preliminary experience. (1999) (87)
- Gd-DTPA in clinical MR of the brain: 2. Extraaxial lesions and normal structures. (1986) (86)
- Quantification of breast tumor microvascular permeability with feruglose-enhanced MR imaging: initial phase II multicenter trial. (2003) (82)
- Influence of physiologic motion on the appearance of tissue in MR images. (1986) (82)
- Macromolecular contrast agents for MR mammography: current status (2003) (80)
- Quantification of liver blood volume: comparison of ultra short ti inversion recovery echo planar imaging (ulstir‐epi), with dynamic 3d‐gradient recalled echo imaging (1995) (78)
- Nuclear magnetic resonance contrast enhancement study of the gastrointestinal tract of rats and a human volunteer using nontoxic oral iron solutions. (1983) (77)
- Brain nuclear magnetic resonance imaging enhanced by a paramagnetic nitroxide contrast agent: preliminary report. (1983) (73)
- Influerce of chemical structure of nitroxyl spin labels on their reduction by ascorbic acid (1985) (72)
- Contrast-Enhanced Magnetic Resonance Imaging Estimation of Altered Capillary Permeability in Experimental Mammary Carcinomas After X-Irradiation (1994) (72)
- Gd-DTPA contrast enhancement and tissue differentiation in MR imaging of experimental breast carcinoma. (1986) (70)
- MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model (2003) (67)
- Cerebral Erdheim-Chester disease: persistent enhancement with Gd-DTPA on MR images. (1989) (67)
- The allergic theory of radiocontrast agent toxicity: demonstration of antibody activity in sera of patients suffering major radiocontrast agent reactions. (1976) (65)
- Nitroxyl spin label contrast enhancers for magnetic resonance imaging. Studies of acute toxicity and mutagenesis. (1984) (65)
- Heterogeneity in the angiogenic response of a BT474 human breast cancer to a novel vascular endothelial growth factor‐receptor tyrosine kinase inhibitor: Assessment by voxel analysis of dynamic contrast‐enhanced MRI (2005) (64)
- Metalloporphyrin contrast enhancement of tumors in magnetic resonance imaging. A study of human carcinoma, lymphoma, and fibrosarcoma in mice. (1987) (61)
- Magnetic Resonance Macromolecular Agents for Monitoring Tumor Microvessels and Angiogenesis Inhibition (2006) (60)
- Acute myocardial ischemia and reperfusion: MR imaging with albumin-Gd-DTPA. (1989) (60)
- Cranial bone marrow in children: assessment of normal development with MR imaging. (1989) (59)
- Magnetic resonance imaging in an experimental model of human ovarian cancer demonstrating altered microvascular permeability after inhibition of vascular endothelial growth factor. (2000) (58)
- Histologic confirmation of microvascular hyperpermeability to macromolecular MR contrast medium in reperfused myocardial infarction (1998) (58)
- Hypercarbia‐induced changes in cerebral blood volume in the cat: A 1H MRI and intravascular contrast agent study (1992) (58)
- Focal fatty infiltration of the liver: analysis of prevalence and CT findings in children and young adults. (2001) (58)
- Inhaled nitric oxide in neonates with persistent pulmonary hypertension (2001) (57)
- Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats. (2008) (57)
- Contrast-enhanced MRI of tumors. Comparison of Gd-DTPA and a macromolecular agent. (1989) (56)
- Computed tomographic scanning in children: comparison of radiation dose and resolving power of commercial CT scanners. (1978) (55)
- Contrast media as histamine liberators. I. Mast-cell histamine release in vitro by sodium salts of contrast media. (1970) (54)
- Dilute oral iron solutions as gastrointestinal contrast agents for magnetic resonance imaging; initial clinical experience. (1985) (54)
- Myocardial infarction: assessment with an intravascular MR contrast medium. Work in progress. (1991) (52)
- Acute experimental cerebral ischemia: MR enhancement using Gd-DTPA. (1986) (52)
- Quantitative estimation of microvascular permeability in human brain tumors: correlation of dynamic Gd-DTPA-enhanced MR imaging with histopathologic grading. (2002) (51)
- Vascular Mapping using Albumin‐(Gd‐DTPA), an Intravascular MR Contrast Agent, and Projection MR Imaging (1989) (51)
- Contrast-enhanced Magnetic Resonance Imaging of Tumor-bearing Mice Treated with Human Recombinant Tumor Necrosis Factor α (1990) (50)
- Community surveillance for coronary heart disease: the Framingham Cardiovascular Disease Survey. Methods and preliminary results. (1974) (49)
- AUR Memorial Award 1991. Immunogenicity of gadolinium-based contrast agents for magnetic resonance imaging. Induction and characterization of antibodies in animals. (1991) (49)
- Assessment of a rapid clearance blood pool MR contrast medium (P792) for assays of microvascular characteristics in experimental breast tumors with correlations to histopathology (2001) (48)
- Pulmonary metastases at diagnosis of neuroblastoma in pediatric patients: CT findings and prognosis. (2001) (48)
- New macromolecular polymeric MRI contrast agents for application in the differentiation of cancer from benign soft tissues (2008) (47)
- Comparison of albumin‐(Gd‐DTPA)30 and Gd‐DTPA‐24‐cascade‐polymer for measurements of normal and abnormal microvascular permeability (1997) (47)
- Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool and perfusion imaging. (1990) (47)
- Evaluation of radiation-induced liver injury with MR imaging: comparison of hepatocellular and reticuloendothelial contrast agents. (1992) (47)
- Imaging of tumor angiogenesis: current approaches and future prospects. (2006) (46)
- A new polysaccharide macromolecular contrast agent for MR imaging: Biodistribution and imaging characteristics (2000) (44)
- Contrast media as histamine liberators. II. Histamine release into venous plasma during intravenous urography in man. (1970) (44)
- Enhanced MRI of tumors utilizing a new nitroxyl spin label contrast agent. (1985) (44)
- Resection of distal tracheal stenosis in a baby with agenesis of the lung. (1980) (44)
- Femoral neuropathy secondary to the use of a self-retaining retractor (1995) (43)
- Quantitative gadopentetate‐enhanced MRI of breast tumors: Testing of different analytic methods (2000) (43)
- Magnetic Resonance Imaging of Local Soft Tissue Inflammation Using Gadolinium-DTPA (1987) (42)
- Comparison of Initial Biodistribution Patterns of Gd‐DTPA and Albumin‐(Gd‐DTPA) Using Rapid Spin Echo MR Imaging (1987) (42)
- Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases. (1992) (41)
- MR imaging of the arthritic rabbit knee joint using albumin-(Gd-DTPA)30 with correlation to histopathology. (1999) (41)
- Community surveillance for coronary heart disease: the Framingham Cardiovascular Disease survey. Comparisons with the Framingham Heart Study and previous short-term studies. (1976) (40)
- Angiographic properties of Gd-DTPA-24-cascade-polymer--a new macromolecular MR contrast agent. (1995) (40)
- Differentiation of alveolitis and pulmonary fibrosis with a macromolecular MR imaging contrast agent. (1992) (40)
- Magnetic resonance imaging of myocardial infarction using albumin-(Gd-DTPA), a macromolecular blood-volume contrast agent in a rat model. (1987) (40)
- Nonenzymatic bioreduction in rat liver and kidney of nitroxyl spin labels, potential contrast agents in magnetic resonance imaging. (1987) (39)
- Community surveillance for cardiovascular disease: the Framingham cardiovascular disease survey. Some methodological problems in the community study of cardiovascular disease. (1976) (39)
- Antibodies to radiographic contrast agents. Induction and characterization of rabbit antibody. (1976) (39)
- Hemodynamic effects of bolus injection of gadodiamide injection and gadopentetate dimeglumine as contrast media at MR imaging in rats. (1992) (39)
- Gadolinium-DTPA enhanced MR imaging of intramuscular abscesses. (1987) (39)
- Upper airway obstruction in infants and children: evaluation with ultrafast CT. (1987) (38)
- Tumor microvascular changes to anti-angiogenic treatment assessed by MR contrast media of different molecular weights. (2002) (38)
- Nuclear magnetic resonance imaging in orthopaedics: Principles and applications (1983) (37)
- Allergic reactions to contrast media: accumulated evidence. (1980) (37)
- Decrease in Tumor Apparent Permeability‐Surface Area Product to a MRI Macromolecular Contrast Medium Following Angiogenesis Inhibition with Correlations to Cytotoxic Drug Accumulation (2004) (35)
- Comparison of gadopentetate dimeglumine and albumin‐(Gd‐DTPA)30 for microvessel characterization in an intracranial glioma model (1998) (35)
- Human erythrocyte membrane permeability and nitroxyl spin-label reduction. (1986) (35)
- Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations. (2007) (34)
- Delay in the prehospital phase of acute myocardial infarction. Lack of influence on incidence of sudden death. (1976) (34)
- Differentiation of capillary leak and hydrostatic pulmonary edema with a macromolecular MR imaging contrast agent. (1991) (34)
- The Choice of Region of Interest Measures in Contrast-Enhanced Magnetic Resonance Image Characterization of Experimental Breast Tumors (2005) (34)
- AUR memorial Award. Induced alignment of flowing sickle erythrocytes in a magnetic field. A preliminary report. (1985) (33)
- Computed tomographic scanning in children: II. An updated comparison of radiation dose and resolving power of commercial scanners. (1982) (33)
- Definition of liver tumors in the presence of diffuse liver disease: comparison of findings at MR imaging with positive and negative contrast agents. (1997) (33)
- Quantification of capillary permeability to macromolecular magnetic resonance imaging contrast media in experimental mammary adenocarcinomas. (1994) (33)
- NMR imaging of experimental brain abscess: comparison with CT. (1983) (32)
- Abdominal disease in children: a comparison of computed tomography and ultrasound. (1980) (31)
- Elevated salivary iodine and salivary gland enlargement due to iodinated contrast media. (1971) (30)
- Comparison of Gadomer-17 and gadopentetate dimeglumine for differentiation of benign from malignant breast tumors with MR imaging. (2000) (30)
- MR monitoring of cyclooxygenase-2 inhibition of angiogenesis in a human breast cancer model in rats. (2007) (30)
- Safety aspects and pharmacokinetics of inhaled aerosolized gadolinium (1993) (29)
- Macromolecular contrast media-enhanced MRI estimates of microvascular permeability correlate with histopathologic tumor grade. (1998) (29)
- Initial Computed Tomography Imaging Experience Using a New Macromolecular Iodinated Contrast Medium in Experimental Breast Cancer (2005) (26)
- Abdominal pseudotumor in childhood: distended gallbladder with parenteral hyperalimentation. (1981) (26)
- Aerosolized gadolinium-DTPA enhances the magnetic resonance signal of extravascular lung water. (1987) (26)
- Contrast‐enhanced MRI of periarticular soft‐tissue changes in experimental arthritis of the rat (1986) (26)
- Detection of zonal renal ischemia with contrast‐enhanced MR imaging with a macromolecular blood pool contrast agent (1992) (25)
- Computed body tomography in children: evaluation of 45 patients. (1978) (25)
- Nuclear magnetic resonance imaging of vasculature of abdominal viscera: normal and pathologic features. (1983) (25)
- Tumor angiography using high-resolution, three-dimensional magnetic resonance imaging: comparison of gadopentetate dimeglumine and a macromolecular blood-pool contrast agent. (1995) (25)
- Magnetic resonance imaging of the thorax in childhood. Work in progress. (1984) (25)
- Pharmacokinetics and Metabolic Fate of Two Nitroxides Potentially Useful as Contrast Agents for Magnetic Resonance Imaging (1984) (24)
- Nephrogenic systemic fibrosis in rats treated with erythropoietin and intravenous iron. (2009) (23)
- Endotracheal tube orifice abutting the tracheal wall: a cause of infant airway obstruction. (1981) (22)
- In Vivo Monitoring of Angiogenesis Inhibitory Treatment Effects by Dynamic Contrast-Enhanced Computed Tomography in a Xenograft Tumor Model (2009) (22)
- Arthritic temporomandibular joint: correlation of macromolecular contrast-enhanced MR imaging parameters and histopathologic findings. (1997) (21)
- Magnetic resonance imaging of acute myocardial infarction using a nitroxyl spin label (PCA). (1985) (21)
- Adrenocortical carcinoma with extension into inferior vena cava and right atrium: Report of 3 cases in children (2005) (21)
- Magnetic resonance characterization of tumor microvessels in experimental breast tumors using a slow clearance blood pool contrast agent (carboxymethyldextran-A2-Gd-DOTA) with histopathological correlation (2005) (21)
- Considerations in the choice of contrast media for MR imaging. (1988) (21)
- Recurrent neuroblastoma: the role of CT and alternative imaging tests. (1983) (21)
- Noninvasive assessment of wound-healing angiogenesis with contrast-enhanced MRI. (2002) (21)
- MRI monitoring of tumor response to a novel VEGF tyrosine kinase inhibitor in an experimental breast cancer model. (2002) (19)
- Nuclear magnetic resonance imaging of the brain in children. (1984) (19)
- Permeability to macromolecular contrast media quantified by dynamic MRI correlates with tumor tissue assays of vascular endothelial growth factor (VEGF). (2012) (19)
- [Magneto-pharmaceutic contrast changes in nuclear magnetic resonance tomography]. (1986) (19)
- Diradical nitroxyl spin label contrast agents for magnetic resonance imaging. A comparison of relaxation effectiveness. (1986) (19)
- Contrast media as histamine liberators. 3. Histamine release and some associated hemodynamic effects during pulmonary angiography in the dog. (1971) (18)
- Magnetic resonance imaging in cystic fibrosis. (1984) (18)
- MR imaging of liver abscesses; application of Gd-DTPA. (1988) (17)
- Contrast media toxicity in children (2008) (17)
- Assessment of severity of experimental pulmonary edema with magnetic resonance imaging. Effect of relaxation enhancement by Gd-DTPA. (1985) (17)
- Contrast-enhanced magnetic resonance imaging of tumor-bearing mice treated with human recombinant tumor necrosis factor alpha. (1990) (17)
- Magnetic Resonance Imaging Enhancement of Normal Tissues and Tumors Using Macromolecular Gd-Based Cascade Polymer Contrast Agents: Preclinical Evaluations (2006) (17)
- Magnetic field dependence of spin-lattice relaxation enhancement using piperidinyl nitroxyl spin-labels. (1985) (17)
- Comparison of vascular opacification after bolus injection of iodixanol-320 iohexol-350. (1992) (17)
- Follow-up of Wilms tumor: comparison of CT with other imaging procedures. (1981) (16)
- The effect of gastrografin and glucagon on CT scanning of the pancreas: a blind clinical trial. (1978) (15)
- Airway obstruction in pediatric patients. From croup to BOOP. (1998) (15)
- Magnetic resonance imaging contrast enhancement versus tissue gadolinium concentration. (1990) (15)
- Partial aortic obstruction produced by a thoracostomy tube. (1981) (15)
- Incidence and significance of a widened esophageal hiatus at CT scan. (1984) (15)
- Introduction to the Gadolinium Class (1993) (15)
- Amelioration of cardiodepressive effects of gadopentetate dimeglumine with addition of ionic calcium. (1992) (15)
- Ultrafast computed tomography for infants and children. (1988) (15)
- MRI tumor characterization using Gd-GlyMe-DOTA-perfluorooctyl-mannose-conjugate (Gadofluorine M), a protein-avid contrast agent. (2006) (15)
- Dynamic MRI enhanced with albumin-(Gd-DTPA)30 or ultrasmall superparamagnetic iron oxide particles (NC100150 injection) for the measurement of microvessel permeability in experimental breast tumors. (2002) (14)
- Work in progress: Nuclear magnetic resonance study of a paramagnetic nitroxide contrast agent for enhancement of renal structures in experimental animals (1984) (14)
- Evidence Supporting an Antibody Mediation of Contrast Media Reactions (1980) (13)
- Contrast enhancement in experimental radiation‐induced liver injury: Comparison of hepatocellular and reticuloendothelial particulate contrast agents (1996) (13)
- Gastrointestinal complications of renal transplantation in children. (1979) (13)
- Influence of chemical structure on nitroxyl spin label magnetic relaxation characteristics (1989) (12)
- CT of the thoracic duct. (1983) (12)
- Magnetic resonance imaging demonstration of pharmacologic-induced myocardial vasodilatation using a macromolecular gadolinium contrast agent. (1992) (12)
- Distribution of intracellular, extracellular, and intravascular contrast media for magnetic resonance imaging in hearts subjected to reperfused myocardial infarction. (1996) (12)
- Quantification of tissue gadolinium concentration using magnetic resonance imaging: comparison of ultrashort inversion time inversion recovery echoplanar and dynamic three-dimensional spoiled gradient-recalled approaches with in vitro measurements. (1996) (12)
- Pseudolymphoma in two immunodeficient children. (1979) (11)
- Magnetic Resonance Imaging Detects Early Changes in Microvascular Permeability in Xenograft Tumors after Treatment with the Matrix Metalloprotease Inhibitor Prinomastat (2004) (11)
- Comparison of Ionic and Non-Ionic Nitroxide Spin Labels for Urographic Enhancement in Magnetic Resonance Imaging (1987) (11)
- Correlative dynamic contrast MRI and microscopic assessments of tumor vascularity in RIP‐tag2 transgenic mice (2009) (11)
- Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. (1987) (11)
- Community surveillance for cerebrovascular disease: the Framingham Cardiovascular Disease Survey. (1978) (11)
- Metabolic fate in the dog of the nitroxide moiety in a compound with potential utility as a contrast agent in MRI (1987) (11)
- Facilitated magnetic resonance imaging diagnosis of pulmonary disease using a macromolecular blood-pool contrast agent, polylysine-(Gd-DTPA)40. (1991) (11)
- Pulmonary oxygen toxicity: Demonstration of abnormal capillary permeability using contrast-enhanced MRI (2005) (10)
- Gadolinium accumulation and fibrosis in the liver after administration of gadoxetate disodium in a rat model of active hepatic fibrosis. (2012) (10)
- Orbital tumors in children. Characterization by computed tomography. (1984) (10)
- Magnetic Resonance Imaging Assays for Dimethyl Sulfoxide Effect on Cancer Vasculature (2008) (10)
- MRI contrast enhancement in the central nervous system : a case study approach (1993) (10)
- Paramagnetic pharmaceuticals for magnetic resonance imaging. (1984) (10)
- Tumor blood volume assays using contrast-enhanced magnetic resonance imaging: regional heterogeneity and postmortem artifacts. (1999) (9)
- Magnetic Resonance Imaging of Vascular Lesions in Children (1984) (9)
- Mapping abnormal synovial vascular permeability in temporomandibular joint arthritis in the rabbit using MRI. (1996) (9)
- Chapter 28. Contrast Enhancing Agents in NMR Imaging (1985) (9)
- Medially deployed thoracostomy tubes: cause of aortic obstruction in newborns. (1981) (9)
- Inherent contrast in magnetic resonance imaging and the potential for contrast enhancement. The 1984 L. Henry Garland lecture. (1985) (9)
- In-vivo NIR autofluorescence imaging of rat mammary tumors. (2006) (9)
- Pharmacokinetics in the rat and the dog of a nonionic nitroxide contrast agent for magnetic resonance imaging. (1988) (9)
- Quantitative density-time measurements in the lungs of children with suspected airway obstruction using ultrafast CT (2006) (9)
- Experimental acute pancreatitis: MR relaxation time studies using gadolinium–DTPA (1988) (9)
- The case strengthens for allergy to contrast media. (1998) (8)
- Comparison of MR contrast-enhancing properties of albumin-(biotin)10-(gadopentetate)25, a macromolecular MR blood pool contrast agent, and its microscopic distribution. (2002) (8)
- Pyrroxamide, a nonionic nitroxyl spin label contrast agent for magnetic resonance imaging. Mutagenesis and cell survival. (1988) (8)
- Clinical nuclear magnetic resonance imaging of the body. (1983) (8)
- Hydropneumothorax: detection on supine radiographs. (1984) (8)
- Ascorbate-induced cancellation of nitroxide contrast media enhancement of MR images. (1989) (7)
- Macromolecular magnetic resonance imaging contrast media. Accumulated experience. (1990) (7)
- Can a small-molecular gadolinium contrast agent be applied successfully with dynamic MRI to quantitatively define brain tumor microvascular responses to angiogenesis inhibition? (2002) (7)
- Kinetics of MRI Contrast Agents with a Size Ranging Between Gd-DTPA and Albumin-Gd-Dtpa Use of CASCADE-Gd-DTPA-24 Polymer (1998) (7)
- Spin Labeled Bovine Serum Albumin, Spin Labeled Bovine Serum Albumin Chelating Agents and Their Gadolinium Complexes. Potential Contrast Enhancing Agents for Magnetic Resonance Imaging (1986) (7)
- Optimizing imaging techniques to reduce errors in microvascular quantitation with macromolecular MR contrast agents. (1998) (7)
- [Contrast agents in magnetic resonance imaging]. (1985) (6)
- Utility (or not) of Gd-DTPA-based dynamic MRI for breast cancer diagnosis and grading. (2002) (6)
- Evaluation of imatinib mesylate as a possible treatment for nephrogenic systemic fibrosis in a rat model. (2013) (6)
- Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model. (2013) (6)
- Radiographic assessment of venous catheter position in children: value of the lateral view (2005) (6)
- [Gadolinium-DTPA tolerance and clinical safety]. (1997) (5)
- ENHANCEMENT OF MYOCARDIAL INFARCTIONS WITH NUCLEAR MAGNETIC RESONANCE CONTRAST MEDIA (1984) (5)
- Direct magnification radiography of the newborn infant. (1982) (5)
- The pre-hospital phase of acute myocardial infarction and sudden death. I. Prodromata of acute coronary events. (1976) (5)
- The Role of Blood Pool Contrast Media in the Study of Tumor Pathophysiology (2005) (5)
- Evaluation of spin labeled tartaric and galactaric diamides as potential MRI contrast enhancing agents (1989) (5)
- Introduction: SMRM workshop. Contrast enhanced magnetic resonance (1991) (5)
- Mixture model approach to tumor classification based on pharmacokinetic measures of tumor permeability (2005) (5)
- Assessment of acute and reperfused myocardial ischemia using GdDTPA, GdDTPA-cascade-24-polymer and albumin-GdDTPA. (1998) (4)
- [Effects of MRI-assayed microvascular permeability on the accumulation of vinorelbine in xenograft tumors]. (2010) (4)
- Work in progress: Methods of contrast enhancement for NMR imaging and potential applications — A subject review (1984) (4)
- Synthesis of Water Soluble Spin Labeled Glucose Derivatives as Potential NMR Contrast Enhancing Agents (1986) (4)
- Allergy to Radiographic Contrast Media: Accumulated Evidence for Antibody-mediated Human Toxicity and a New Animal Model (1982) (4)
- 72. MRI OF CANINE MYOCARDIAL INFARCTION WITH PARAMAGNETIC CONTRAST AGENTS (1984) (4)
- Spin Labeled Chelating Agents and their Gadolinium Complexes as Contrast Enhancing Agents for NMR Imaging (1985) (4)
- Plasma Histamine Concentrations in Subjects Undergoing; Intravenous Urography (1970) (3)
- IN VITRO AND IN VIVO TESTING OF METAL‐ION COMPLEXES USED AS NUCLEAR MAGNETIC RESONANCE CONTRAST MEDIA (1984) (3)
- Contrast-enhancing properties of Gd-DTPA at 2.0 Tesla. (1987) (3)
- A macromolecular contrast agent for magnetic resonance imaging. Effect of molecular weight on blood pharmacokinetics and enhancement patterns for polylysine-gadopentetate dimeglumine. (1994) (3)
- Magnetic resonance imaging of experimental renal hemorrhage. (1987) (3)
- IRON‐CONTAINING COMPOUNDS USED AS GASTROINTESTINAL CONTRAST MEDIA IN ANIMALS AND HUMANS (1984) (3)
- NSFR: NMR CONTRAST AGENT FOR THE CNS (1983) (3)
- The right paratracheal stripe in children (1978) (3)
- CT localization of occult secretory tumors in children (2004) (3)
- 77. DIMERIC NITROXYL CONTRAST AGENTS FOR NMR IMAGING (1984) (2)
- 76. PROTON RELAXATION ENHANCEMENT AND STABILITY OF NITROXIDE SPIN LABELS: A METHOD FOR NMR CONTRAST MEDIA DESIGN (1984) (2)
- [Macromolecular contrast media for MR mammography. A new approach to characterizing breast tumors]. (1997) (2)
- INHIBITION STUDIES OF ANTI-CONTRAST MEDIUM ANTIBODIES (1981) (2)
- Computed tomography in the evaluation of pediatric genitourinary disease. (1980) (2)
- Contrast agents for nuclear magnetic resonance imaging (1987) (2)
- Extragonadal endodermal sinus (Yolk Sac) tumor Angiographic findings and literature review (1978) (2)
- Cardiosynchronous MRI intensity changes of the great vessels and pulmonary circulation. A preliminary report. (1985) (2)
- Pharmacokinetics of Two Prototype Nitroxide Spin Labels for Contrast Enhancement in Magnetic Resonance Imaging (1985) (2)
- Clinical comparison of CR and screen film for imaging the critically ill neonate (1996) (2)
- A QUANTITATIVE COMPARISON OF CONVENTIONAL AND MAGNIFICATION RADIOGRAPHY OF INFANTS (1981) (2)
- 169 COMPARISON OF IONIC AND NON-IONIC CONTRAST MEDIA FOR RENAL ENHANCEMENT IN NMR IMAGING (1985) (2)
- Definition of peritumoral vessels with contrast-enhanced magnetic resonance imaging: comparison of gadopentetate dimeglumine and a blood-pool macromolecular contrast medium. (1996) (2)
- GASTROINTESTINAL CONTRAST ENHANCEMENT FOR NMR IMAGING USING NONTOXIC ORAL IRON SOLUTIONS (1983) (2)
- Extracting kinetic information from dynamic imaging protocols (2002) (1)
- 121. NMR CONTRAST ENHANCEMENT OF ACUTE MYOCARDIAL ISCHEMIA USING THE PARAMAGNETIC PHARMACEUTICAL GADOLINIUM-DTPA (1984) (1)
- Magnetic resonance imaging in pediatric hematology/oncology. Part 1. Basic technology (1986) (1)
- The Incidence of Colonic Ischemia with Retroperitoneal Aortic Reconstruction: A Prospective Study Emphasizing Early Selective Endoscopic Intervention (1998) (1)
- Development of Magnetic Resonance Contrast Media for Tumors (1986) (1)
- Utility of computed tomography in the diagnosis of thoracic aneurysm in childhood (2007) (1)
- Magnetic resonance imaging in pediatric diagnosis. (1987) (1)
- Potential radiosensitizing effect in vivo of nitroxyl spin labels. (1985) (1)
- Magnetic resonance imaging for pediatric diagnosis. (1987) (1)
- [Specific and non-specific contrast media for MRI of tumors. Experimental study of human breast carcinoma]. (1989) (1)
- Time and dose dependency of radiation-induced changes in tumor microvascular characteristics using contrast-enhanced magnetic resonance imaging: impact on the delivery of chemotherapeutic agents. (1996) (1)
- MRI mapping of microvascular permeability and tissue blood volume (2006) (1)
- Magnetic resonance imaging in pediatric hematology/oncology. Part II. Illustrative cases and assessment of technique. (1986) (1)
- 172 MRI CONTRAST ENHANCEMENT OF EXPERIMENTALLY INDUCED ABCESSES. A COMPARISON OF Gd-DTPA AND A NEW NON-IONIC NITROXIDE SPIN LABEL (1985) (1)
- Some questions and answers about radiographic contrast media reactions and allergy (1986) (1)
- Method for attaining in vivo tissue-specific contrast by nuclear magnetic resonance imaging (1991) (1)
- Magnetic resonance (MR) imaging of aorta and pulmonary circulation. Initial experience with ECG-gating. (1985) (1)
- CMR 2005: 3.01: MRI tumor characterization using Gd–GlyMe–DOTA-perfluorooctylmannose conjugate (Gadofluorine M), a novel protein-avid contrast agent (2006) (1)
- Radiologic evaluation of the thymus in juvenile myasthenia gravis (1978) (1)
- Unilateral hypoplasia of the hemithorax causing “pseudoscoliosis” after lung irradiation in a child with Wilms' tumor (2006) (1)
- Artifacts, variants, and factors degrading image quality in pediatric magnetic resonance imaging (2006) (1)
- Preparation of an Aminoxyl Analog of the Anticancer Agent Miltefosine (1996) (1)
- Monitoring the Acute Microvascular Effects of Anti-Inflammatory Steroid Treatment in a Rat Arthritis Model Using Macromolecular Contrast-Enhanced Magnetic Resonance Imaging (2005) (1)
- Spatial mapping of microvascular permeability and tissue blood volume using magnetic resonance imaging. (1996) (0)
- Adverse Reactions and Their Pathophysiology and Management (1999) (0)
- United States Patent ( 19 ) Engelstad et al . METHOD FOR ATTAINING IN VIVO TSSUE-SPECIFC CONTRAST BY NUCLEAR MAGNETC RESONANCE (2017) (0)
- Magnetic resonance imaging in pediatric hematology/oncology. Part I. Basic technology. (1986) (0)
- Acute Renal Failure After Intravenous Urography: Detection of Antibodies Against Contrast Media (1975) (0)
- [Comparative animal experiment study of aseptic abscesses using MRI: use of Gd-DTPA]. (1986) (0)
- Toward the Goal of Signal Quantification in Contrast-Enhanced Optical Imaging (2005) (0)
- 93rd annual convention podium and poster abstracts (1994) (0)
- Portable infant elevator for neonatal magnification radiography. (1979) (0)
- 4972837 Contrast agents for nuclear magnetic resonance imaging (1992) (0)
- Computed tomography of the pediatric abdomen, a review. (1982) (0)
- Acute microvascular effects of anti-angiogenic treatment in a rat model of human breast cancer using macromolecular contrast-enhanced magnetic resonance imaging (2005) (0)
- CMR 2007: 2.04: Novel macromolecular iodinated contrast medium permits assays of cancer microvascular leakiness in response to anti‐VEGF antibody using dynamic CT (2007) (0)
- New dimensions of contrast media : proceedings of the Second International Symposium on Contrast Media, Osaka, Japan, November 9-10, 1990 (1991) (0)
- Tumor Necrosis Factor α Effects Studied in a Mouse Model Using Contrast-Enhanced Magnetic Resonance Imaging (1992) (0)
- 122. RELATIVE INTENSITY OP ABDOMINAL ORGANS IN MRI (1984) (0)
- New developments in MRI contrast enhancement (1994) (0)
- Fast CT assists diagnosis of pulmonary embolism. (1995) (0)
- The fork-lift infant elevator for neonatal magnification radiography. (1980) (0)
- Imaging of Tumorangiogenesis (2014) (0)
- Contrast-enhanced Magnetic Resonance Imaging of Tumor-bearing Mice Treated with Human Recombinant Tumor Necrosis Factor a1 (2006) (0)
- Synthesis of Water Soluble Spin Labeled Glucose Derivatives as Potential NMR Contrast Enhancing Agents. (1987) (0)
- Clinical evaluation of CR versus plain film for neonatal ICU applications (1995) (0)
- 173 PARAMAGNETIC MRI ENHANCEMENT OF IMPLANTED BREAST CARCINOMA (1985) (0)
- Nuclear Magnetic Resonance Session (1984) (0)
- Dr. Brasch's Comments: (1982) (0)
- Plain Radiographic Examination of the Heart and Chest (2007) (0)
- Single Metal Deposition of Cop per , Cadmium , Zinc and Nickel from Thiosulfate Solu tions (2017) (0)
- Challenges for the development of clinically useful fluorescing diagnostic contrast agents for optical imaging: a radiologist's perspective (2004) (0)
- 106. Imaging of Myocardial Infarction in Rats Albumin-(Gd-DTPA), a Macromolecular, Blood-Volume Contrast Agent (1987) (0)
- Magnetic resonance imaging in pediatric practice. (1986) (0)
- CONTRAST MEDIA FOR NUCLEAR MAGNETIC RESONANCE IMAGING (1984) (0)
- Contrast media (1984) (0)
- CMR 2007: 2.02: Characterizing cancer microvasculature: correlations of dynamic macromolecular contrast media-enhanced MRI with microscopic morphology (2007) (0)
- Imaging Tumor Angiogenesis Using Contrast-Enhanced Magnetic Resonance Imaging (1999) (0)
- Patent Number : 45 Date of Patent : 54 USE OF PARAMAGNETIC METAL LOPORPHYRNS AS CONTRAST AGENTS FORTUMORS NMR (2017) (0)
- Myocardial Salvage After Ischemia and Reperfusion Using Magnetic Resonance Imaging and Spectroscopy (2005) (0)
- Clinical nuclear magnetic resonance imaging of the body (1984) (0)
- TRACHEAL DIAMETERS AND DYNAMICS IN INFANTS AND CHILDREN MEASURED BY CINE-CT (1985) (0)
- Postgraduate Course: Table of Contents (2008) (0)
- Pediatric Radiology (1962) (0)
- CMR 2007: 7.01: Development of new dendrimeric MRI contrast agents with poly(ethylene glycol) cores: toward the selection of the single best compound (2007) (0)
- In-vivo NIR autofluorescence of rat mammary tumors discriminates pathological malignancy (2003) (0)
- Radiology Editorial Board (2006) (0)
- 120 CONTRAST-ENHANCED MRI OF PERIARTICULAR SOFT TISSUE CHANGES IN RHEUMATOID-LIKE ARTHRITIC RATS (1985) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Robert C. Brasch?
Robert C. Brasch is affiliated with the following schools:
